CN1290570C - Medical liquor for treating bronchial asthma and drug administering apparatus thereof - Google Patents
Medical liquor for treating bronchial asthma and drug administering apparatus thereof Download PDFInfo
- Publication number
- CN1290570C CN1290570C CN 200510021430 CN200510021430A CN1290570C CN 1290570 C CN1290570 C CN 1290570C CN 200510021430 CN200510021430 CN 200510021430 CN 200510021430 A CN200510021430 A CN 200510021430A CN 1290570 C CN1290570 C CN 1290570C
- Authority
- CN
- China
- Prior art keywords
- bronchial asthma
- bottle
- medical liquid
- medicinal liquid
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention discloses medical liquid for treating bronchial asthma and an application device thereof, which belongs to the technical field of traditional Chinese medicines. The medical liquid for treating bronchial asthma comprises the following steps: ginger, garlic, lemon, mint and licorice root prepared according to the certain proportion are used as raw medicinal materials; after the raw materials are soaked for 10 days by edible wine, soak liquid is extracted to be mixed with table vinegar according to the certain volume proportion to be prepared into medical liquid; next, the prepared medical liquid is added to a bottle to a medical level scale (5) from a bottle jack of the upper end of a bottle body (1) of the application device, and a bottle stopper (2) is plugged; thus, the treatment is carried out. The medical liquid for treating bronchial asthma uses common Chinese medicinal materials as the raw medicinal materials, so the medical liquid has the advantages of convenient acquisition of materials, low cost, good therapeutic effect, short course of treatment, obvious effect and high cure rate. In addition, the medical liquid has little side effect and high safety because of the natural obtainment of the medical liquid. Thus, the medical liquid can be used for treating and preventing bronchial asthma to obtain the effect of health care.
Description
Technical field
The present invention relates to the field of Chinese medicines, concretely, the present invention relates to a kind of medicinal liquid and doser thereof for the treatment of bronchial asthma.
Background technology
Because the difference of factors such as climatic environment, living condition, occupation, the prevalence of various places asthma is different.The investigation report of external several countries points out that the prevalence of childhood asthma is 0.3%-7.4%, and the prevalence of adult's asthma is 1.1%-9.9%.According to some areas investigation, the prevalence 0.5%-2% of China's asthma also has report up to 5.29%.Asthma can occur in any age, and adult men and women sickness rate is roughly similar.Most data at home and abroad show, rural area or the area of being partial to nature, and the prevalence of asthma is starkly lower than the flourishing city of industry.In recent years, along with the development of processing and chemical engineering industry, atmospheric pollution was more serious, the trend that the pathogenesis of asthma rate rises again gradually, and according to the U.S., over nearly 30 years, the pathogenesis of asthma rate has increased by 7 times, now is 4%.China Shanghai, two the regional partial investigations in Beijing, the former asthma prevalence from 1958 0.46% rise to 1979 0.69%, the latter's pathogenesis of asthma rate from 4.5% of nineteen fifty-nine bring up to 1980 5.29%.
Bronchial asthma is the respiratory tract chronic inflammation disease that is participated in by various kinds of cell (as: eosinophilic granulocyte, mastocyte, T lymphocyte, neutrophil cell, airway epithelial cell etc.) and cellular component.This chronic inflammatory disease causes the increase of airway hyperreactivity, and cause symptoms such as out of breath, the uncomfortable in chest or cough of panting of repeated relapsing, extensively changeable reversibility flow limitation usually appears in the be everlasting outbreak of night or early morning, aggravation, but most of patients spontaneous remission or alleviate through treatment.
Summary of the invention
Goal of the invention of the present invention provides a kind of medicinal liquid for the treatment of bronchial asthma, and another goal of the invention of the present invention provides the doser of the medicinal liquid of this treatment bronchial asthma.
The medicinal liquid of treatment bronchial asthma of the present invention, it comprises that weight portion is Rhizoma Zingiberis Recens 100-300 part, Bulbus Allii 200-400 part, Fructus Citri Limoniae 300-700 part, the crude drug of Herba Menthae 5-6 part, it is in 30 °-38 ° the edible wine that crude drug is immersed in alcoholic strength, soaks at least 10 days, take out soak and tablet vinegar and be hybridly prepared into medicinal liquid, wherein the percent by volume of soak and tablet vinegar is respectively 50-60% and 40-50%.
Also have in the described crude drug: Radix Glycyrrhizae 3-9 part.
Choosing when stating crude drug, should select Rhizoma Zingiberis Recens of fine quality, Bulbus Allii, Fructus Citri Limoniae, Herba Menthae and Radix Glycyrrhizae, wherein Fructus Citri Limoniae should be a lemon; Remove silt and non-impurity of the drug in the selected crude drug then, clear water is cleaned, Rhizoma Zingiberis Recens and Fructus Citri Limoniae section, Bulbus Allii peeling.
Soak and tablet vinegar are hybridly prepared into medicinal liquid and are finished product after sterilization, bottlings.
What deserves to be mentioned is, for nephropathy or renal insufficiency person being arranged or the steeping in wine with the Radix Glycyrrhizae weight portion being reduced to 3-4 part in the crude drug or not adding of moist disease patient being arranged.
Crude drug of the present invention is selected Rhizoma Zingiberis Recens, Bulbus Allii, Fructus Citri Limoniae, Herba Menthae and Radix Glycyrrhizae combination for use.This is that slightly warm in nature wherein contains oiliness volatile oil such as zingiberol, zingiberene, water benzene alkene, citral and fragrance because the Rhizoma Zingiberis Recens flavor is peppery; Also have gingerol, resin, starch and fiber etc.Has appetite promoting and the spleen strengthening, the effect of refreshment, but stimulating gastrointestinal road mucosa, increase pipe intestinal digesting liquid and the capable water of spleen, effects such as diuresis are because the main immune immunne response mistake of allergic asthma, cause the allergy of I type, and the spleen main immune organ that is human body, nearly all immunne response is all carried out at this in the body, thereby Rhizoma Zingiberis Recens can be prevented and treated allergic asthma.Bulbus Allii has the activity of broad-spectrum antiviral, multiple virus is had suppress and killing action, and the asthma that causes for respiratory tract infection has better action; Bulbus Allii also has the effect of anti-inflammation, and 20% volatile oil is arranged in the Bulbus Allii approximately, contains a kind of strong phytocide in this volatile oil, and Bulbus Allii has the asthma that control causes because of hypertrophy; Bulbus Allii can be improved immunologic function, experimental results show that, garlic injection can strengthen the function of intraperitoneal mouse macrophage phagocytic virus, antibacterial, also has the effect of bringing out human lymphocyte simultaneously, human body immunocyte quantity is increased, thereby enhancing immunity prevents and treats asthma from many aspects, reaches the purpose of relievining asthma.Fructus Citri Limoniae, property is flat, sour in the mouth, go into lung, stomach is secret.Main treatment lung is done and the dryness of the lung, the asthma patient is had the function of moistening and cleaning throat, sharp lung.Herba Menthae, peppermint stem and leaf has peat-reek, has dispelling wind and heat pathogens, the clear sharp head, sore-throat relieving, effect such as moves thoroughly, and coming into leaves to stop the angiogenic growth at cancerous lesion place, reduces the bronchial asthma and the antitumaous effect that cause because of the human body cell canceration.Radix Glycyrrhizae, has Detoxication, glycyrrhizin have the effect of adrenocortical hormone sample, thereby it is antitoxin, anti-inflammatory, deleterious material there is adsorption, glycyrrhizin can be acted on its enzyme hydrolysis again by specialty, produce glycoside unit and glucuronic acid, the latter can combine with the metabolite and the poisonous substance of most drug, present Detoxication, thereby suppress to retain in vivo because of the metabolite of the initiation asthma that produces after the drug metabolism, Radix Glycyrrhizae aspect relieving cough and asthma, enoxolone choline salt the most effectively wherein, asthma patient there is curative effect preferably, a kind of main component---glycyrrhizin is arranged in the Radix Glycyrrhizae, the function of energy enhancing human body immunity system, thereby can be from antibacterial, prevent obesity, aspects such as human body immunity improving power prevent and treat asthma.
The present invention adopts edible wine infusion crude drug, and soak and tablet vinegar are hybridly prepared into medicinal liquid.Be because of tablet vinegar, sour in the mouth, warm in nature, analgesic, detumescence, detoxifcation, contained aminoacid has the human body of raising metabolic function, the outbreak of fundamentally consolidating the human body prevention of asthma in the vinegar.Edible wine: ethanol can dissolve the active drug composition in the various infusion things, strengthen pulmonary's band oxygen amount, vasodilator, when human body sucks the air that has volatilization ethanol (the various useful effect compositions that have crude drug), make the effective ingredient of various medicines act on the oral cavity, immune organ such as throat and pulmonary and spleen plays the auxiliary treatment effect.
The doser of the medicinal liquid of treatment bronchial asthma of the present invention is:
The bottle stopper that there is a bottleneck bottle upper end and matches, a drug location reticle is arranged on the sidewall of bottle bottom, an air inlet is arranged on the sidewall of bottle bottom, a suction tube is arranged on the sidewall on bottle top, the medicinal liquid for preparing is added in the bottle from bottleneck, the drug location reticle place that the medicinal liquid liquid level reaches on the bottle gets final product, then bottle stopper beyond the Great Wall.The patient slowly sucks pulmonary from the suction inlet of suction tube deeply with the gas of top in the bottle during treatment, and this device makes the patient more can the concentrated area absorb the effective ingredient of medicinal liquid, reaches excellent curative.
Because the medicinal liquid of treatment bronchial asthma of the present invention all is that employing Chinese crude drug commonly used is a crude drug, draw materials conveniently, with low cost, have excellent curative, the short treating period instant effect, the cure rate height, and it is natural that this medicinal liquid is got, and side effect is little, safe, both can be used for treating bronchial asthma, can be used for preventing the bronchial asthma health care again.
Description of drawings
Accompanying drawing is the structure chart of doser of the medicinal liquid of treatment bronchial asthma of the present invention.
The specific embodiment
Embodiment 1:
The medicinal liquid of treatment bronchial asthma takes by weighing each crude drug by following weight proportion:
Rhizoma Zingiberis Recens 300g Bulbus Allii 400g
Fructus Citri Limoniae 700g Herba Menthae 6g
Radix Glycyrrhizae 9g.
It is in 30 °-38 ° the Chinese liquor that crude drug is immersed in alcoholic strength, soaks at least 10 days, takes out soak and tablet vinegar and is hybridly prepared into medicinal liquid, and wherein the percent by volume of soak and tablet vinegar is respectively 60% and 40%.
Choosing when stating crude drug, should select Rhizoma Zingiberis Recens of fine quality, Bulbus Allii, Fructus Citri Limoniae, Herba Menthae and Radix Glycyrrhizae, wherein Fructus Citri Limoniae should be a lemon; Remove silt and non-impurity of the drug in the selected crude drug then, clear water is cleaned, Rhizoma Zingiberis Recens and Fructus Citri Limoniae section, Bulbus Allii peeling.
The medicinal liquid that soak and tablet vinegar are hybridly prepared into is finished product after sterilization, bottling.
The doser of the medicinal liquid of treatment bronchial asthma is:
As shown in Figure 1, the bottle stopper 2 that there is a bottleneck bottle 1 upper end and matches has a drug location reticle 5 on the sidewall of bottle 1 bottom, an air inlet 13 is arranged on the sidewall of bottle 1 bottom, and a suction tube 4 is arranged on the sidewall on bottle 1 top.During treatment the medicinal liquid for preparing is added in the bottle from bottleneck, drug location reticle 5 places that the medicinal liquid liquid level reaches on the bottle get final product, then bottle stopper 2 beyond the Great Wall.
Embodiment 2:
The medicinal liquid of treatment bronchial asthma takes by weighing each crude drug by following weight proportion:
Rhizoma Zingiberis Recens 150g Bulbus Allii 300g
Fructus Citri Limoniae 400g Herba Menthae 6g
Radix Glycyrrhizae 7g.
The wine of infusion crude drug is that alcoholic strength is 30 °-38 ° a fruit wine, and the percent by volume of soak and tablet vinegar is respectively 50% and 50% during the mixed preparing medicinal liquid.
Other are with embodiment 1.
Embodiment 3:
The medicinal liquid of treatment bronchial asthma takes by weighing each crude drug by following weight proportion:
Rhizoma Zingiberis Recens 100g Bulbus Allii 200g
Fructus Citri Limoniae 300g Herba Menthae 5g
Radix Glycyrrhizae 4g.
Other are with embodiment 1.
This scheme Radix Glycyrrhizae consumption reduces, and is applicable to the patient who also has moist disease.
Embodiment 4:
The medicinal liquid of treatment bronchial asthma takes by weighing each crude drug by following weight proportion:
Rhizoma Zingiberis Recens 200g Bulbus Allii 300g
Fructus Citri Limoniae 600g Herba Menthae 6g
Radix Glycyrrhizae 8g
Other are with embodiment 1.
Embodiment 5:
The medicine of treatment bronchial asthma takes by weighing each crude drug by following weight proportion:
Rhizoma Zingiberis Recens 250g Bulbus Allii 350g
Fructus Citri Limoniae 600g Herba Menthae 6g
Other are with embodiment 1.
Do not have Radix Glycyrrhizae in this scheme, be applicable to the patient who also suffers from nephropathy or renal insufficiency.
The case brief introduction:
The inventor uses theory of Chinese medical science by concentrating on studies and testing, and the science compatibility has formed the medicinal liquid for the treatment of bronchial asthma.
Inventor oneself is exactly an allergic bronchitis patient, and the state of an illness is very serious, breathes all very difficultly, and after self using 2 months, sx, reuse are after 1 month, and symptom is eliminated, so far the not recurrence of the time of half a year.
Patient: Yuan Chongxin, the address: two groups in seven villages, Jin Quan township, Xichong County, Sichuan Province, suffered from asthma 5 years, the medicinal liquid treatment of using this treatment bronchial asthma is after 4 months, and symptom is eliminated substantially.
Patient: He Jun, the address: three groups in the peaceful Zhen Er in Sichuan Province village, asthma medical history 10 years, use the medicinal liquid of this treatment bronchial asthma to treat half a year after, the state of an illness takes a turn for the better gradually, symptom is controlled substantially.
Patient: Wen Fang, address: two groups in seven villages, Jin Quan township, Xichong County, Sichuan Province, bronchial asthma 26 years, seeking medical advice does not everywhere all have effect, is the difficult and complicated illness of the well-known distance in Jin Quan township, and the patient is extremely painful, the medicinal liquid treatment of using this treatment bronchial asthma is after 1 month, symptom alleviates to some extent, treats 1 year again, and symptom obviously alleviates.
By foregoing invention people oneself and some asthma patients' on every side thereof treatment, use the therapeutic effect highly significant of this medicinal liquid, make its science obtain checking.
Claims (4)
1, a kind of medicinal liquid for the treatment of bronchial asthma, it is characterized in that it comprises that weight portion is Rhizoma Zingiberis Recens 100-300 part, Bulbus Allii 200-400 part, Fructus Citri Limoniae 300-700 part, the crude drug of Herba Menthae 5-6 part, it is in 30 °-38 ° the edible wine that crude drug is immersed in alcoholic strength, soaks at least 10 days, take out soak and tablet vinegar and be hybridly prepared into medicinal liquid, wherein the percent by volume of soak and tablet vinegar is respectively 50-60% and 40-50%.
2, the medicinal liquid of treatment bronchial asthma according to claim 1 is characterized in that also having in the crude drug: Radix Glycyrrhizae 3-9 part.
3, the medicinal liquid of treatment bronchial asthma according to claim 1 is characterized in that Fructus Citri Limoniae should be a lemon, and section.
4, the doser of the medicinal liquid of treatment bronchial asthma according to claim 1, comprise bottle (1), the bottle stopper (2) that there is a bottleneck bottle (1) upper end and matches, it is characterized in that: on the sidewall of bottle (1) bottom a drug location reticle (5) is arranged, on the sidewall of bottle (1) bottom an air inlet (3) is arranged, on the sidewall on bottle (1) top a suction tube (4) is arranged.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510021430 CN1290570C (en) | 2005-08-09 | 2005-08-09 | Medical liquor for treating bronchial asthma and drug administering apparatus thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510021430 CN1290570C (en) | 2005-08-09 | 2005-08-09 | Medical liquor for treating bronchial asthma and drug administering apparatus thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1733289A CN1733289A (en) | 2006-02-15 |
| CN1290570C true CN1290570C (en) | 2006-12-20 |
Family
ID=36076045
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510021430 Expired - Fee Related CN1290570C (en) | 2005-08-09 | 2005-08-09 | Medical liquor for treating bronchial asthma and drug administering apparatus thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1290570C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101259262B (en) * | 2008-04-17 | 2011-02-09 | 尚小勤 | Inhalation for improving immunity and preparation thereof |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108686128A (en) * | 2018-08-01 | 2018-10-23 | 符国安 | Bronchitis, early stage pulmonary emphysema fumigant and preparation method thereof |
-
2005
- 2005-08-09 CN CN 200510021430 patent/CN1290570C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101259262B (en) * | 2008-04-17 | 2011-02-09 | 尚小勤 | Inhalation for improving immunity and preparation thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1733289A (en) | 2006-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1290570C (en) | Medical liquor for treating bronchial asthma and drug administering apparatus thereof | |
| CN1872306A (en) | Preparation of Chinese traditional medicine for treating baby's cough, and preparation method | |
| CN1301120C (en) | Medicine for treating breadth gasp, cough, asthma and phelgm | |
| CN1899461A (en) | Medicine for treating chicken kindney infectious bronchitis | |
| CN1583001A (en) | Infrared cough relieving paste | |
| CN1251736C (en) | Chinese medicinal infusion for treating shingles, parotitis acute mamitis and its manufacturing method | |
| CN1284585C (en) | Medicine for treating acute and chronic pharyogolaryngitis, recurring oral cavity sore and its preparation method | |
| CN1088817A (en) | The Chinese medicine preparation of treatment tracheitis is coughed rather | |
| CN1294930C (en) | Medication for treating cough caused by inflammation of upper respiratory tract | |
| CN1895395A (en) | Xiaoer Kechuanling soft extract for treating infantile cough and asthma and its preparing method | |
| CN1229129C (en) | cough-relieving plaster | |
| CN1255159C (en) | Chinese medicine for treating rhinitis | |
| CN101057705A (en) | Natural tobacco additive capable of reducing gas impurity, reducing stimulus and promoting tobacco fragrant | |
| CN1256959C (en) | Rhinitis treating medicinal cream | |
| CN101143199A (en) | Traditional Chinese medicine for treating chronic bronchitis | |
| CN1915400A (en) | Medication for treating symptoms of the illness of nasosinusitis | |
| CN101028429A (en) | Chinese-medicinal composition for treating bronchial asthma | |
| CN1281257C (en) | Combination of Chinese herbal medicine for curing chronic tracheitis and chronic bronchitis | |
| CN101433672B (en) | Chinese medicament preparation for treating nosebleed and preparation method thereof | |
| CN101607001B (en) | Throat tablet for moisturizing and removing heat | |
| CN1876075A (en) | A medicine for treating asthma, acute and chronic bronchitis and preparation method thereof | |
| CN1634340A (en) | Medicinal composition for preventing and treating children respiratory system diseases and preparation method thereof | |
| CN1943732A (en) | A medicinal composition for treatment of psoriasis | |
| CN1256962C (en) | Medicine for treating throat disease and its preparation method | |
| CN1872244A (en) | Composition of Chinese traditional medicine for treating disorder of erection function |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |